Press Releases Year None20212020201920182017 Atreca to Present at Upcoming Virtual Investor Conferences November 8, 2021 PDF Version READ MORE Atreca Reports Third Quarter 2021 Financial Results and Recent Corporate Developments November 2, 2021 PDF Version READ MORE Atreca Enters into Licensing Agreement with Bill & Melinda Gates Medical Research Institute to Develop a Monoclonal Antibody for the Prevention of Malaria October 21, 2021 PDF Version READ MORE Atreca Announces Poster Presentations at the Society for Immunotherapy of Cancer (SITC) Annual Meeting October 1, 2021 PDF Version READ MORE Atreca to Present at Upcoming Virtual Investor Conferences September 8, 2021 PDF Version READ MORE Atreca Reports Second Quarter 2021 Financial Results and Recent Corporate Developments August 11, 2021 PDF Version READ MORE Atreca to Present at Upcoming Virtual Investor Conferences August 4, 2021 PDF Version READ MORE Atreca Presents Initial Clinical Data from Phase 1b Trial of ATRC-101 in Select Advanced Solid Tumors July 29, 2021 PDF Version READ MORE Atreca to Host Webcast Presentation of Initial Clinical Data from Phase 1b Trial of ATRC-101 July 26, 2021 PDF Version READ MORE Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors July 19, 2021 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 16
